Nisa Investment Advisors’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293 Hold
95
﹤0.01% 2932
2025
Q4
$343 Hold
95
﹤0.01% 2867
2025
Q3
$358 Sell
95
-281
-75% -$1.08K ﹤0.01% 2896
2025
Q2
$1.46K Buy
376
+9
+2% +$49 ﹤0.01% 2669
2025
Q1
$1.83K Sell
367
-78
-18% -$494 ﹤0.01% 2491
2024
Q4
$3.21K Buy
445
+169
+61% +$1.29K ﹤0.01% 2372
2024
Q3
$1.7K Buy
276
+99
+56% +$671 ﹤0.01% 2440
2024
Q2
$1.18K Buy
177
+35
+25% +$258 ﹤0.01% 2482
2024
Q1
$1.45K Buy
142
+29
+26% +$295 ﹤0.01% 2290
2023
Q4
$1.27K Hold
113
﹤0.01% 2223
2023
Q3
$294 Buy
+113
New +$324 ﹤0.01% 2615

Other funds holding ALT

Nisa Investment Advisors's ALT Position: Q1 2026 in Review

Nisa Investment Advisors held its Altimmune (ALT) position steady in Q1 2026 at 95 shares worth $293. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Nisa Investment Advisors first reported a position in ALT in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.21K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Nisa Investment Advisors held 95 shares of Altimmune worth $293 as of Q1 2026.
  • Nisa Investment Advisors left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2932 holding.
  • Nisa Investment Advisors first reported a position in Altimmune in Q3 2023 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Altimmune position peaked at $3.21K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.